BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder

  October 15, 2024

   · 

  9 min read
• Press Releases

  Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

  October 15, 2024

   · 

  9 min read
• Press Releases

  Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting

  October 15, 2024

   · 

  8 min read
• Press Releases

  Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024

  October 15, 2024

   · 

  2 min read
• Press Releases

  IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer

  October 15, 2024

   · 

  2 min read
• Press Releases

  Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference

  October 15, 2024

   · 

  8 min read
• Press Releases

  Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

  October 15, 2024

   · 

  2 min read
• Business

  NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

  October 15, 2024

   · 

  1 min read
• Press Releases

  Neurosurgeon Joseph Georges, P.I. for Diakonos Oncology’s Phase 1 Trial of Its Unique Dendritic Cell Vaccine for Gliobastoma, Receives the CNS 2024 Rosenblum-Mahaley Clinical Research Award

  October 15, 2024

   · 

  3 min read
• Press Releases

  Airway Therapeutics to Launch a Multinational Phase 3 Trial of Zelpultide Alfa for Preterm Neonates at Risk of Bronchopulmonary Dysplasia

  October 15, 2024

   · 

  2 min read